Institut Pasteur, Center for Translational Research, Paris, France.
Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Int J Infect Dis. 2021 May;106:134-139. doi: 10.1016/j.ijid.2021.03.054. Epub 2021 Mar 22.
The Cambodia pertussis immunization schedule includes three doses given at age 6, 10 and 14 weeks using a whole-pertussis vaccine. No booster doses are included. Pertussis biological diagnosis is unavailable in Cambodia and its burden remains unclear. This study aimed to provide accurate data on pertussis serological status of Cambodian children and adolescents, and to evaluate vaccination timeliness.
Fully vaccinated children aged 3-15 years were recruited at the Rabies Prevention Center, Institut Pasteur in Cambodia, Phnom Penh. Capillary blood samples and information on pertussis vaccination history were collected. Anti-pertussis toxin (PT) IgG titers were quantified by ELISA.
Compliance with the national immunization schedule was 95.1%. Initiation of vaccination after 8 weeks of age was observed for 29.0% of the children, but was less frequent in the youngest children (13.0%) compared with the oldest ones (46.4%). Rate of children exhibiting anti-PT IgG varied across age groups, and increased from 35.7% to 55.0% in 3-5 and 12-15 years age groups, respectively.
Pertussis circulates among vaccinated Cambodian children and adolescents. These data support the need for public health authorities to strengthen pertussis surveillance and use local epidemiological data to make evidence-based decision for the establishment of an optimal vaccination strategy.
柬埔寨的百日咳免疫计划包括在 6、10 和 14 周龄时使用全菌体百日咳疫苗接种 3 剂。不包括加强剂量。柬埔寨没有百日咳的生物学诊断方法,其负担也不清楚。本研究旨在提供柬埔寨儿童和青少年百日咳血清学状况的准确数据,并评估疫苗接种的及时性。
在柬埔寨金边巴斯德研究所狂犬病预防中心招募了 3-15 岁的完全接种疫苗的儿童。采集毛细血管血样,并收集百日咳疫苗接种史信息。采用 ELISA 法定量检测抗百日咳毒素(PT)IgG 滴度。
95.1%的儿童符合国家免疫计划。29.0%的儿童在 8 周龄后开始接种疫苗,但在年龄最小的儿童(13.0%)中比年龄最大的儿童(46.4%)中更少见。具有抗-PT IgG 的儿童比例在不同年龄组之间存在差异,分别从 3-5 岁组的 35.7%增加到 55.0%和 12-15 岁组的 55.0%。
在接种疫苗的柬埔寨儿童和青少年中,百日咳仍在传播。这些数据支持公共卫生当局加强百日咳监测,并利用当地流行病学数据,为制定最佳疫苗接种策略做出循证决策。